The UAE is the first in the world after the FDA in adopting a promising innovative new drug for Covid-19 patients
The Ministry of Health and Prevention announced the granting of the emergency use of a new effective drug for Covid-19 produced by GSK Global, making the United Arab Emirates the first in the world after the US Food and Drug Administration approved and approved the emergency use of it, which enables the immediate use of this treatment in the country. It will reduce the number of cases requiring hospitalization for more than 24 hours and reduce the number of deaths due to infection with Covid 19 virus by up to 85% when given to patients as early treatment.
The United Arab Emirates granted the emergency use of the drug "Sotrovimab-VIR-7831", which depends on "monoclonal antibodies" to treat patients aged 12 years and over who face a high risk of developing severe Covid-19 symptoms and hospitalization due to the repercussions of the disease.
The Minister of Health and Community Protection, Abdul Rahman bin Muhammad Al Owais, said that this qualitative achievement comes within the framework of the UAE’s keenness to establish its leadership and precedence in an effective response to the pandemic as a global example by attracting and providing innovative medicines that have proven effective and efficient, and approved within the treatment protocols, in a way that contributes to Significantly, in accelerating the recovery of patients, reducing the length of stay in intensive care and reducing deaths, in addition to continuing to conduct examinations and provide vaccines among the countries of the world in efficiently dealing with the Covid 19 pandemic.
His Excellency added that this achievement is the result of the wise leadership’s keenness to harness the best capabilities and resources and protect the gains that have been achieved during the past period at all levels, stressing the importance of the partnership between the health sector in the country and international research institutions and the private medical and pharmaceutical sector and relying on science and innovation. It is considered one of the lessons learned from the Covid-19 pandemic, in which the UAE has proven its success in facing the largest health crisis in modern history, as the discovery of innovative solutions and treatments in order to provide distinct and effective health care, especially during the spread of epidemics, can help governments deal with health crises in a timely manner. More effective and effective.
The Undersecretary of the Ministry of Health and Community Protection and Chairman of the Board of Directors of the Emirates Foundation for Health Services, Dr.Mohammed Salim Al-Olama, affirmed that the UAE has worked with determination since the early days of the pandemic to be an active part in the unprecedented global efforts to research and develop new tests, vaccines and medicines, as well as working to be the state The first in adopting, licensing and launching the latest technologies to protect the health of society.
The ministry's strategy is based on adopting promising new technologies in its efforts to control the Covid-19 virus.
He said that the Ministry has strengthened its partnership with GSK, the world leader in the pharmaceutical industry, as part of its keenness to ensure early access to innovative modern medicines, from licensing and shipments to training and guidelines for doctors on appropriate use, and how to direct patients to the facilities where the new drug will be available.
Dr. Al-Olama pointed out that the UAE is a pioneer in registering innovative medicines globally, according to an innovative mechanism that has been designated to evaluate and approve pioneering or first-of-its-kind medicines in the world.
Within the fast track for drug evaluation and registration.
Noting that the approval of this innovative drug comes in implementation of Federal Law No. 8 of 2019 regarding medical products, the pharmacy profession and pharmaceutical facilities.
The selection of the innovative company GSK for Sotrovimab (Vir 7831) to the UAE as the first country in the world to license and supply the first shipments of the new drug for Covid-19, based on the long-established strategic partnership, and based on the confidence in the UAE's global standing, and the clear vision of the country's leadership and its belief that Reaching a radical solution to the pandemic comes through broad international solidarity and cooperation, in addition to the quality and efficiency of the health system, its logistical capabilities, and its world-leading infrastructure.
The approval of a new drug that studies have proven effective in treating the mutated virus and the emerging mutations from it and helps to speed up the recovery of the infected and reduce deaths among Covid-19 patients represents a positive development in the ongoing battle against the virus, "in conjunction with the progress made by the UAE in providing vaccines and treatments, and what is evident. On those positive results that we have reached today is the high incidence of recovery and also a significant decrease in the death rate.
"We are working in close partnership with the Ministry of Health and Community Protection to ensure the availability of innovative medicines and vaccines for patients who need them, a mission that has gained new urgency during the epidemic, within the framework of GSK's commitment to provide the best scientific developments to patients in the country," said the managing director and vice president of GSK Gulf, Gizem Akalin. The Emirates and the Arab Gulf region. "
Follow our latest local and sports news, and the latest political and economic developments via Google news